Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Sales | 5,127 | 4,887 | 5,087 | 4,403 | 2,881 |
| Gross Profit | 5,127 | 4,887 | 5,087 | 4,403 | 2,881 |
| Operating Expenses | 51,097 | 43,553 | 32,862 | 26,362 | 18,431 |
| Operating Income | -45,970 | -38,666 | -27,775 | -21,959 | -15,550 |
| Interest Expense | 0 | -430 | 451 | 1 | 4 |
| Other Income | 845 | 496 | 293 | 1,068 | 466 |
| Pre-tax Income | -45,125 | -37,740 | -27,933 | -20,892 | -15,088 |
| Income Tax | -1,209 | N/A | -491 | N/A | N/A |
| Net Income Continuous | -43,916 | -38,231 | -27,442 | -20,892 | -15,088 |
| Net Income | $-43,916 | $-38,231 | $-27,442 | $-20,892 | $-15,088 |
| EPS Basic Total Ops | -0.90 | -0.86 | -0.63 | -0.48 | -0.36 |
| EPS Basic Continuous Ops | -0.90 | -0.86 | -0.63 | -0.48 | -0.36 |
| EPS Diluted Total Ops | -0.90 | -0.86 | -0.63 | -0.48 | -0.36 |
| EPS Diluted Continuous Ops | -0.90 | -0.86 | -0.63 | -0.48 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.90 | -0.85 | N/A | N/A | N/A |
| EBITDA(a) | $-43,670 | $-36,726 | $-25,777 | $-20,904 | $-15,307 |